| Code | CSB-RA006945MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to the reference antibody CBA-1205, targeting DLK1 (Delta-like 1 homolog), a non-canonical member of the Notch/Delta/Serrate family. DLK1 is a transmembrane protein that functions as an important regulator of cell differentiation and stem cell maintenance across multiple tissue types. This protein plays critical roles in adipogenesis, hematopoiesis, and neuroendocrine cell development. Aberrant DLK1 expression has been implicated in various pathological conditions, including hepatocellular carcinoma, neuroblastoma, and other malignancies where it contributes to tumor cell proliferation and maintenance of cancer stem cell populations. Additionally, DLK1 is associated with metabolic disorders and serves as a diagnostic marker for certain neuroendocrine tumors.
As a biosimilar to CBA-1205, this antibody provides researchers with a reliable tool for investigating DLK1-mediated signaling pathways, studying its role in developmental biology, and exploring its therapeutic potential in oncology and metabolic disease research. The antibody enables detailed characterization of DLK1 expression patterns and functional studies across diverse experimental models.
There are currently no reviews for this product.